4D Molecular Therapeutics logo

4D Molecular Therapeutics FDMT

$ 9.13 7.86%

Quarterly report 2025-Q3
added 11-10-2025

report update icon

Country

usaUSA

IPO year

2020

Industry

-

Stock Exchange

NASDAQ GLOBAL

Shares

53.9 M

Market Cap[1]

$ 493 M

EBITDA (LTM)

$ -221 M

P/E (LTM)

-2.32

P/S (LTM)

3736.27

EPS (LTM)

-3.64

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.